AAAAAA
Results: 26-50/51
Authors:
LIPTON SA
BRENNEMAN DE
SILVERSTEIN FS
MASLIAH E
MUCKE L
Citation: Sa. Lipton et al., GP120 AND NEUROTOXICITY IN-VIVO, Trends in pharmacological sciences, 16(4), 1995, pp. 122-122
Authors:
BRENNEMAN DE
HILL JM
GLAZNER GW
GOZES I
PHILLIPS TW
Citation: De. Brenneman et al., INTERLEUKIN-1-ALPHA AND VASOACTIVE-INTESTINAL-PEPTIDE - ENIGMATIC REGULATION OF NEURONAL SURVIVAL, International journal of developmental neuroscience, 13(3-4), 1995, pp. 187-200
Authors:
GOZES I
FRIDKIN M
BRENNEMAN DE
Citation: I. Gozes et al., A VIP HYBRID ANTAGONIST - FROM DEVELOPMENTAL NEUROBIOLOGY TO CLINICAL-APPLICATIONS, Cellular and molecular neurobiology, 15(6), 1995, pp. 675-687
Authors:
VONAGOSTON D
PALKOVITS CG
FITZGERALD SF
BRENNEMAN DE
Citation: D. Vonagoston et al., DEVELOPMENTAL-CHANGES IN THE INDUCIBILITY OF FOS-LIKE IMMUNOREACTIVITY IN PRIMARY EMBRYONIC SPINAL-CORD CULTURES, Developmental brain research, 89(2), 1995, pp. 173-186
Authors:
MCCUNE SK
BRENNEMAN DE
HILL JM
Citation: Sk. Mccune et al., THE ACUTE EFFECT OF DEXAMETHASONE ADMINISTRATION OF VIP MESSENGER-RNAEXPRESSION IN THE RAT CNS, Pediatric research, 37(4), 1995, pp. 383-383
Authors:
GOZES I
LILLING G
GLAZER R
TICHER A
ASHKENAZI IE
DAVIDSON A
RUBINRAUT S
FRIDKIN M
BRENNEMAN DE
Citation: I. Gozes et al., SUPERACTIVE LIPOPHILIC PEPTIDES DISCRIMINATE MULTIPLE VASOACTIVE-INTESTINAL-PEPTIDE RECEPTORS, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 161-167
Authors:
BRENNEMAN DE
GOZES I
Citation: De. Brenneman et I. Gozes, A FEMTOMOLAR ACTING NEUROPROTECTIVE PEPTIDE, Journal of neurochemistry, 65, 1995, pp. 203-203
LIPOPHILIC AND HYBRID PEPTIDES - NOVEL DRUGS FOR NONINVASIVE TREATMENT OF NEURODEGENERATIVE DISEASES
Authors:
GOZES I
LILLING G
BARDEA A
RESHEF A
WOLLMAN Y
RUBINRAUT S
FRIDKIN M
BRENNEMAN DE
Citation: I. Gozes et al., LIPOPHILIC AND HYBRID PEPTIDES - NOVEL DRUGS FOR NONINVASIVE TREATMENT OF NEURODEGENERATIVE DISEASES, Journal of neurochemistry, 65, 1995, pp. 203-203
Authors:
BRENNEMAN DE
MCCUNE SK
MERVIS RF
HILL JM
Citation: De. Brenneman et al., GP120 AS AN ETIOLOGIC AGENT FOR NEUROAIDS - NEUROTOXICITY AND MODEL SYSTEMS, Advances in neuroimmunology, 4(3), 1994, pp. 157-165
Authors:
BRENNEMAN DE
MCCUNE SK
MERVIS RF
HILL JM
Citation: De. Brenneman et al., GP120 AS AN ETIOLOGIC AGENT FOR NEUROAIDS - NEUROTOXICITY AND MODEL SYSTEMS, Advances in neuroimmunology, 4(3), 1994, pp. 157-165
Authors:
LILLING G
WOLLMAN Y
GOLDSTEIN MN
RUBINRAUT S
FRIDKIN M
BRENNEMAN DE
GOZES I
Citation: G. Lilling et al., INHIBITION OF HUMAN NEUROBLASTOMA GROWTH BY A SPECIFIC VIP ANTAGONIST, Journal of molecular neuroscience, 5(4), 1994, pp. 231-239
Authors:
SONE M
SMITH DM
GHATEI MA
GOZES I
BRENNEMAN DE
FRIDKIN M
BLOOM SR
Citation: M. Sone et al., PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) VASOACTIVE-INTESTINAL-PEPTIDE (VIP) RECEPTOR SUBTYPES IN RAT-TISSUES - INVESTIGATION OF RECEPTOR-BINDING, A NOVEL VIP RECEPTOR ANTAGONIST AND CHEMICALCROSS-LINKING, Biomedical research, 15(3), 1994, pp. 145-153
Authors:
OLAH Z
LEHEL C
ANDERSON WB
BRENNEMAN DE
VONAGOSTON D
Citation: Z. Olah et al., SUBNANOMOLAR CONCENTRATION OF VIP INDUCES THE NUCLEAR TRANSLOCATION OF PROTEIN-KINASE-C IN NEONATAL RAT CORTICAL ASTROCYTES, Journal of neuroscience research, 39(4), 1994, pp. 355-363
Authors:
GOZES I
GLOWA J
BRENNEMAN DE
MCCUNE SK
LEE E
WESTPHAL H
Citation: I. Gozes et al., LEARNING DEFICIENCIES IN TRANSGENIC MICE WITH REDUCED BRAIN VASOACTIVE-INTESTINAL-PEPTIDE, Polish Journal of Chemistry, 68(5), 1994, pp. 1057-1060
Authors:
FATATIS A
HOLTZCLAW LA
AVIDOR R
BRENNEMAN DE
RUSSELL JT
Citation: A. Fatatis et al., VASOACTIVE-INTESTINAL-PEPTIDE INCREASES INTRACELLULAR CALCIUM IN ASTROGLIA - SYNERGISM WITH ALPHA-ADRENERGIC RECEPTORS, Proceedings of the National Academy of Sciences of the United Statesof America, 91(6), 1994, pp. 2036-2040
Authors:
GOZES I
LILLING G
GLAZER R
TICHER A
ASHKENAZI IE
DAVIDSON A
RUBINRAUT S
FRIDKIN M
BRENNEMAN DE
Citation: I. Gozes et al., PHARMACOLOGICAL DISCRIMINATION OF MULTIPLE VIP RECEPTORS WITH SUPERACTIVE LIPOPHILIC PEPTIDES, Journal of neurochemistry, 63, 1994, pp. 190000010-190000010
Authors:
GRESSENS P
HILL JM
GOZES I
FRIDKIN M
BRENNEMAN DE
Citation: P. Gressens et al., PRENATAL ADMINISTRATION OF VIP ANTAGONIST PRODUCES SEVERE MICROCEPHALY, Journal of neurochemistry, 63, 1994, pp. 190000010-190000010
Authors:
VONAGOSTON D
SANTHA E
BRENNEMAN DE
MATSUMOTO K
DOBI AL
Citation: D. Vonagoston et al., GENE STRUCTURE AND THE MOLECULAR ESTABLISHMENT OF THE NEURONAL PHENOTYPE, Journal of neurochemistry, 63, 1994, pp. 190000018-190000018
Authors:
GRESSENS P
HILL JM
PAINDAVEINE B
GOZES I
FRIDKIN M
BRENNEMAN DE
Citation: P. Gressens et al., SEVERE MICROCEPHALY INDUCED BY BLOCKADE OF VASOACTIVE-INTESTINAL-PEPTIDE FUNCTION IN THE PRIMITIVE NEUROEPITHELIUM OF THE MOUSE, The Journal of clinical investigation, 94(5), 1994, pp. 2020-2027
Authors:
GOZES I
GLOWA J
BRENNEMAN DE
MCCUNE SK
LEE E
WESTPHAL H
Citation: I. Gozes et al., LEARNING AND SEXUAL DEFICIENCIES IN TRANSGENIC MICE CARRYING A CHIMERIC VASOACTIVE-INTESTINAL-PEPTIDE GENE, Journal of molecular neuroscience, 4(3), 1993, pp. 185-193
Authors:
SUMMERS RW
WU XR
FITZGERALD SC
BRENNEMAN DE
VONAGOSTON D
Citation: Rw. Summers et al., EXCITATORY AMINO-ACID REGULATION OF THE ENKEPHALIN PHENOTYPE IN MOUSEEMBRYONIC SPINAL-CORD CULTURES, Developmental brain research, 73(2), 1993, pp. 185-192
Authors:
GRESSENS P
HILL JM
GOZES I
FRIDKIN M
BRENNEMAN DE
Citation: P. Gressens et al., VASOACTIVE-INTESTINAL-PEPTIDE ACTS AS A GROWTH-FACTOR IN WHOLE CULTURED MOUSE EMBRYOS, Neurology, 43(4), 1993, pp. 300-300
Authors:
MOODY TW
ZIA F
DRAOUI M
BRENNEMAN DE
FRIDKIN M
DAVIDSON A
GOZES I
Citation: Tw. Moody et al., A VASOACTIVE-INTESTINAL-PEPTIDE ANTAGONIST INHIBITS NONSMALL CELL LUNG-CANCER GROWTH, Proceedings of the National Academy of Sciences of the United Statesof America, 90(10), 1993, pp. 4345-4349
Authors:
BRENNEMAN DE
PAGE SW
SCHULTZBERG M
THOMAS FS
ZELAZOWSKI P
BURNET P
AVIDOR R
STERNBERG EM
Citation: De. Brenneman et al., A DECOMPOSITION PRODUCT OF A CONTAMINANT IMPLICATED IN L-TRYPTOPHAN EOSINOPHILIA-MYALGIA-SYNDROME AFFECTS SPINAL-CORD NEURONAL CELL-DEATH AND SURVIVAL THROUGH STEREOSPECIFIC, MATURATION AND PARTLY INTERLEUKIN-1-DEPENDENT MECHANISMS, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 1029-1035
Authors:
GOZES I
GLOWA J
BRENNEMAN DE
MCCUNE SK
LEE E
WESTPHAL H
Citation: I. Gozes et al., VIP FUNCTION ASSESSED BY MOLECULAR-GENETIC TECHNIQUES, Journal of neurochemistry, 61, 1993, pp. 190000086-190000086